Concentrix Corporation (NASDAQ:CNXC) Receives Consensus Rating of "Hold" from Analysts

Key Points

• Analyst consensus: Five analysts give Concentrix a consensus rating of "Hold" (1 sell, 1 hold, 3 buy) with an average 1‑year price target of $48.50.
• Recent results and financial health: Concentrix missed EPS expectations with $2.61 vs. $2.65 consensus while revenue was $2.50B (up 5.4% YoY); the company still shows a negative net margin (-13.35%) and a debt‑to‑equity ratio of 1.43, with shares trading near $29.60 and a market cap of $1.81B.
• Shareholder moves and payout: The company declared a quarterly dividend of $0.36 ($1.44 annualized, ~4.9% yield) payable May 5, and insiders (CFO and CEO) recently bought shares while institutional investors own about 90.34% of the stock.

Concentrix Corporation (NASDAQ:CNXC - Get Free Report) has received an average rating of "Hold" from the five research firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $48.50.

Several equities research analysts have issued reports on the stock. Canaccord Genuity Group lowered their target price on shares of Concentrix from $80.00 to $55.00 and set a "buy" rating on the stock in a research note on Wednesday, March 25th. Weiss Ratings cut shares of Concentrix from a "hold (c-)" rating to a "sell (d)" rating in a research note on Thursday, January 29th. Wall Street Zen cut shares of Concentrix from a "buy" rating to a "hold" rating in a research note on Saturday, March 28th. Robert W. Baird lowered their target price on shares of Concentrix from $52.00 to $40.00 and set an "outperform" rating on the stock in a research note on Wednesday, March 25th. Finally, Barrington Research lowered their target price on shares of Concentrix from $62.00 to $38.00 and set an "outperform" rating on the stock in a research note on Wednesday, March 25th.

Concentrix Trading Up 2.7%

Shares of CNXC opened at $29.60 on Friday. Concentrix has a 52-week low of $24.27 and a 52-week high of $62.14. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.43. The firm's fifty day moving average is $30.90 and its two-hundred day moving average is $37.37. The stock has a market cap of $1.81 billion, a PE ratio of -1.37, a price-to-earnings-growth ratio of 0.36 and a beta of 0.50.

Concentrix (NASDAQ:CNXC - Get Free Report) last announced its earnings results on Tuesday, March 24th. The company reported $2.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.65 by ($0.04). Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The business had revenue of $2.50 billion for the quarter, compared to analyst estimates of $2.49 billion. During the same period last year, the firm earned $2.79 EPS. The company's revenue for the quarter was up 5.4% compared to the same quarter last year. Research analysts forecast that Concentrix will post 10.11 earnings per share for the current fiscal year.

Concentrix Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 5th. Stockholders of record on Friday, April 24th will be issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 4.9%. The ex-dividend date is Friday, April 24th. Concentrix's payout ratio is currently -6.68%.

Insider Buying and Selling at Concentrix

In related news, CFO Andre S. Valentine purchased 2,500 shares of Concentrix stock in a transaction dated Thursday, April 9th. The shares were acquired at an average price of $27.95 per share, for a total transaction of $69,875.00. Following the acquisition, the chief financial officer directly owned 89,066 shares in the company, valued at approximately $2,489,394.70. The trade was a 2.89% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Christopher A. Caldwell purchased 1,000 shares of Concentrix stock in a transaction dated Thursday, January 29th. The shares were bought at an average price of $37.07 per share, for a total transaction of $37,070.00. Following the acquisition, the chief executive officer owned 362,075 shares in the company, valued at approximately $13,422,120.25. This trade represents a 0.28% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.90% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of CNXC. Royal Bank of Canada raised its holdings in shares of Concentrix by 9.5% during the 1st quarter. Royal Bank of Canada now owns 47,501 shares of the company's stock worth $2,643,000 after acquiring an additional 4,133 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Concentrix by 75.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company's stock worth $23,552,000 after acquiring an additional 181,546 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Concentrix by 17.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company's stock worth $8,152,000 after acquiring an additional 21,746 shares during the period. Focus Partners Wealth purchased a new position in shares of Concentrix during the 1st quarter worth $781,000. Finally, Geneos Wealth Management Inc. raised its holdings in Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company's stock valued at $34,000 after buying an additional 522 shares during the period. Hedge funds and other institutional investors own 90.34% of the company's stock.

About Concentrix

Concentrix Inc NASDAQ: CNXC is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.